India Globalization Capital Inc. Common Stock

(AMEX: IGC)
1.19 0.0059 0.5%
Stock Price | May 17, 2019, 3:59 p.m.
0 Followers
Bid: 0.01
Ask: 1.5
Prev. Close: 1.18
52 Week Low: 0.25
52 Week High: 14.58
PE Ratio: 0.0
Dividend Yield: 0.0%

Company Summary

India Globalization Capital Inc is engaged in the development of cannabis-based combination therapies to treat Alzheimer's, pain, nausea, eating disorders, several endpoints of Parkinson's, and epilepsy in humans, dogs, and cats. The company has focused on four products that it is preparing for medical trials, Natrinol, Caesafin, Serosapse, and Hyalolex.

Read more Read less

Recently Viewed Tickers

Premium Changes to the Global Cannabis Stock Index

9 Comments
1 month ago

Premium A Look at the Laggards in the 420 Investor Cannabis Stock Index

39 Comments
2 years ago

Premium 420 Investor Cannabis Stock Survey

8 Comments
2 years ago

Free Cannabis Stock Survey - Public

2 years ago

Free The SNB Kamikaze - January 20, 2015

4 years ago